Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )

study. Subjects may participate in this study if they are at least 18 years of age. Positron emission tomography (PET/CT) imaging will be used to evaluate fluciclovine uptake at sites of

karnofsky performance status
chemoradiotherapy
  • 1 views
  • 25 Jul, 2021
  • 1 location
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies

This is a pilot phase 2 single-arm study, of men with metastatic castration-resistant prostate cancer (mCRPC). Patients will be treated with any of the approved life-prolonging therapies: abiraterone 1000 mg daily plus prednisone 5 mg (or dexamethasone 0.5 mg) daily, enzalutamide 160 mg daily, or docetaxel 50 mg/m2 every two …

docetaxel
testosterone
adenocarcinoma
metastasis
abiraterone
  • 0 views
  • 08 Jul, 2021
  • 1 location
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Using PET/CT Imaging

This phase III trial compares the addition of apalutamide, with or without targeted radiation therapy, to standard of care treatment versus standard of care treatment alone in patients with prostate cancer biochemical recurrence (a rise in the blood level of prostate-specific antigen [PSA] after treatment with surgery or radiation). Diagnostic …

positron emission tomography
androgens
stereotactic body radiation therapy
tumor cells
definitive treatment
  • 0 views
  • 15 Mar, 2021
  • 3 locations
18F-Fluciclovine PET and Multiparametric MR Imaging

The purpose of the study is to investigate the use of the investigational agent Axumin (fluciclovine-F18) with PET/CT imaging in combination with standard MR imaging to detect remaining or

  • 0 views
  • 26 Jan, 2021
  • 1 location
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

This phase I trial studies how well fluciclovine positron emission tomography (PET)/computed tomography (CT) and PSMA PET/CT work in helping doctors understand and classify invasive lobular

  • 0 views
  • 01 Aug, 2021
  • 1 location
Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases

An open-label, single dose, single arm, prospective, multicenter Phase 3 study to establish the diagnostic performance of 18F fluciclovine positron emission tomography (PET) in detecting

  • 0 views
  • 15 Sep, 2021
  • 14 locations
Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

investigated whether PET (18F-FDG and 18F-fluciclovine) can provide additional prognostic value at baseline and in response assessment compared to MRI and established pre-treatment prognostic scores in PCNSL

hodgkin's disease
histological diagnosis
colony stimulating factor
flow cytometry
primary cns lymphoma
  • 32 views
  • 27 Mar, 2021
  • 1 location
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors

The hypothesis of this exploratory clinical trial in patients with high-grade a primary brain tumor who receive chemoradiation is that the PET imaging agents [18F]Fluciclovine and/or [18F]FLT

malignant brain tumor
recurrent tumor
residual tumor
fluciclovine
anticoagulants
  • 1 views
  • 26 Jan, 2021
  • 1 location
Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

This phase II trial studies how well a positron emission tomography (PET)/computed tomography (CT) scan using fluciclovine F18 compared with a PET/CT scan with 68Ga-PSMA works in planning

prostate specific antigen
metastasis
positron emission tomography
ct scan
prostatectomy
  • 6 views
  • 20 Aug, 2021
  • 3 locations
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

This research study is studying a positron emission tomography (PET) agent called 18F-fluciclovine to evaluate how well 18F-fluciclovine-PET scans determine the extent of muscle invasive bladder

bladder tumor
radiopharmaceuticals
invasive bladder cancer
metastasis
bladder cancer
  • 1 views
  • 11 Aug, 2021
  • 1 location